Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study.

DOI
Publisher DOI
PubMed ID
30027103
Abstract
In the Swiss HIV Cohort Study, the number of people who inject drugs with replicating hepatitis C virus (HCV) infection decreased substantially after the introduction of direct-acting antivirals (DAAs). Among men who have sex with men, the increase in DAA uptake and efficacy was counterbalanced by frequent incident HCV infections.
Date Issued
2018-07
Publication Type
Article
Subject(s)
Subjects
DAA HCV MSM PWID viral replication
Language(s)
en
Author(s)
Fehr, Jan
Braun, Dominique
Cavassini, Matthias
Stoeckle, Marcel
Bernasconi, Enos
Hoffmann, Matthias
Rougemont, Mathieu
Additional Credits
Journal
Open Forum Infectious Diseases
Publisher
Oxford University Press
ISSN
2328-8957
Access(Rights)
Unknown
Show full item